MBP metabolic pharmaceuticals limited
Add to My Watchlist 3.23% ! 3.0¢

half yearlys

  1. bigcosmo
    87 Posts.
    clock Created with Sketch.
    20/02/04
    10:21
    Post #: 391050
    Reported a loss of $4.26 m for half year ending 31/12/03.This is after fully expensing $5.04m R & D costs.Income for period $1.4m.Debt free with $16.6m cash in hand after exercising options and strong participation in share purchase plan.Current Phase 2b trials on obesity drug AOD9604 commenced 11/03 but results not expected until Q3/04.In summary--Financials look strong but had hoped for earlier results from trials.
    MBP Price at posting: 0.0¢ Sentiment: None Disclosure: Held
    Likes Created with Sketch.  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The biggest ASX director trades from the last week
right-arrow Created with Sketch.
NEWS Explore the latest ASX Market News
right-arrow Created with Sketch.
AII Becoming the largest conflict-free tungsten supplier in the world
right-arrow Created with Sketch.
NEWS First assay results returned from ongoing drilling at Gold Duke Project
right-arrow Created with Sketch.
NEWS ANSTO continuous piloting confirms exceptional rare earth recoveries
right-arrow Created with Sketch.
NEWS Southern Silver Exploration: Unlocking value at Cerro Las Minitas amid rising metal prices
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.